DURECT Corporation Trading Halted Today; FDA Advisory Committee to Discuss POSIMIR® (bupivacaine extended-release solution) for Post-Surgical Analgesia

| January 16, 2020 4:35 AM

CUPERTINO, Calif., Jan. 16, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that NASDAQ has halted trading of the Company's common stock today.

Become a Subscriber!

You have read all of your free articles this month. Select a plan below to start your subscription today.

Already a subscriber? Login

Print & Digital

Includes home delivery and FREE digital access when you sign up with EZ Pay

$16.25 per month

Buy

Unlimited Digital Access

*Access via computer, tablet, or mobile device

$9.95 per month

Buy

Click here for more options